Cormedix Stock Technical Analysis
| CRMD Stock | USD 7.35 0.49 6.25% |
As of the 6th of February, CorMedix shows the Risk Adjusted Performance of (0.06), standard deviation of 5.29, and Mean Deviation of 3.08. CorMedix technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CorMedix information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if CorMedix is priced correctly, providing market reflects its regular price of 7.35 per share. Given that CorMedix has information ratio of (0.10), we suggest you to validate CorMedix's prevailing market performance to make sure the company can sustain itself at a future point.
CorMedix Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CorMedix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CorMedixCorMedix's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.CorMedix Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 14.86 | Strong Buy | 6 | Odds |
Most CorMedix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CorMedix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CorMedix, talking to its executives and customers, or listening to CorMedix conference calls.
Will Pharmaceuticals sector continue expanding? Could CorMedix diversify its offerings? Factors like these will boost the valuation of CorMedix. Projected growth potential of CorMedix fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CorMedix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 2.21 | Revenue Per Share | Quarterly Revenue Growth 8.102 | Return On Assets | Return On Equity |
CorMedix's market price often diverges from its book value, the accounting figure shown on CorMedix's balance sheet. Smart investors calculate CorMedix's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CorMedix's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CorMedix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CorMedix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CorMedix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CorMedix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CorMedix.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in CorMedix on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding CorMedix or generate 0.0% return on investment in CorMedix over 90 days. CorMedix is related to or competes with Eyepoint Pharmaceuticals, Bicara Therapeutics, Kura Oncology, ProKidney Corp, Savara, Arbutus Biopharma, and Palvella Therapeutics. CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the preve... More
CorMedix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CorMedix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CorMedix upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 39.4 | |||
| Value At Risk | (6.81) | |||
| Potential Upside | 5.52 |
CorMedix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CorMedix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CorMedix's standard deviation. In reality, there are many statistical measures that can use CorMedix historical prices to predict the future CorMedix's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 3.45 |
CorMedix February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 3.46 | |||
| Mean Deviation | 3.08 | |||
| Coefficient Of Variation | (1,138) | |||
| Standard Deviation | 5.29 | |||
| Variance | 28.02 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 3.45 | |||
| Maximum Drawdown | 39.4 | |||
| Value At Risk | (6.81) | |||
| Potential Upside | 5.52 | |||
| Skewness | (3.63) | |||
| Kurtosis | 20.96 |
CorMedix Backtested Returns
CorMedix secures Sharpe Ratio (or Efficiency) of -0.0772, which signifies that the company had a -0.0772 % return per unit of risk over the last 3 months. CorMedix exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CorMedix's Risk Adjusted Performance of (0.06), mean deviation of 3.08, and Standard Deviation of 5.29 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning CorMedix are expected to decrease at a much lower rate. During the bear market, CorMedix is likely to outperform the market. At this point, CorMedix has a negative expected return of -0.42%. Please make sure to confirm CorMedix's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if CorMedix performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.09 |
Very weak reverse predictability
CorMedix has very weak reverse predictability. Overlapping area represents the amount of predictability between CorMedix time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CorMedix price movement. The serial correlation of -0.09 indicates that less than 9.0% of current CorMedix price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.09 | |
| Spearman Rank Test | -0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 4.72 |
CorMedix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
CorMedix Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of CorMedix volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About CorMedix Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of CorMedix on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of CorMedix based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on CorMedix price pattern first instead of the macroeconomic environment surrounding CorMedix. By analyzing CorMedix's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of CorMedix's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to CorMedix specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0202 | 0.0179 | Price To Sales Ratio | 12.61 | 11.98 |
CorMedix February 6, 2026 Technical Indicators
Most technical analysis of CorMedix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CorMedix from various momentum indicators to cycle indicators. When you analyze CorMedix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 3.46 | |||
| Mean Deviation | 3.08 | |||
| Coefficient Of Variation | (1,138) | |||
| Standard Deviation | 5.29 | |||
| Variance | 28.02 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 3.45 | |||
| Maximum Drawdown | 39.4 | |||
| Value At Risk | (6.81) | |||
| Potential Upside | 5.52 | |||
| Skewness | (3.63) | |||
| Kurtosis | 20.96 |
CorMedix February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CorMedix stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | (0.83) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 7.63 | ||
| Day Typical Price | 7.53 | ||
| Price Action Indicator | (0.52) | ||
| Market Facilitation Index | 0.59 |
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |